Načítá se...
Clinical update: The role of angiotensin II receptor blockers in patients with left ventricular dysfunction (Part II of II)
Almost 5 million individuals in the United States have chronic heart failure (HF), which is increasing in prevalence. Angiotensin‐converting enzyme (ACE) inhibitors are standard therapies for HF, although more than 10% of patients with HF are unable to tolerate these agents. Furthermore, ACE inhibit...
Uloženo v:
| Vydáno v: | Clin Cardiol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley Periodicals, Inc.
2006
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654260/ https://ncbi.nlm.nih.gov/pubmed/16028461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960280604 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|